Table 1.
Age, CPSI scores, UPOINT analysis, pain locations, and treatments provided by referring physicians for 1310 CP/CPPS patients evaluated in a single outpatient clinic from 1998–2014
| 1998–2014 | |
|---|---|
|
|
|
| n=1310 | |
| Age | 44.7 (±13.3) |
| CPSI pain | 10.6 (±4.9) |
| CPSI urination | 4.8 (±3.1) |
| CPSI QoL | 7.9 (±3.1) |
| CPSI total | 23.3 (±9.0) |
| UPOINT | |
| U | 941 (71.8%) |
| P | 361 (27.6%) |
| O | 660 (50.4%) |
| I | 440 (33.6%) |
| N | 402 (30.7%) |
| T | 644 (49.2%) |
| Pain location | |
| Perineum | 788 (60.2%) |
| Testicular | 658 (50.2%) |
| Tip of penis | 441 (33.7%) |
| Pubic/bladder | 798 (60.9%) |
| Urination | 553 (42.2%) |
| Ejaculation | 615 (46.9%) |
| Treatment by referring physician* | |
| Alpha-blockers | 806 (61.5%) |
| Antidepressants | 198 (15.1%) |
| Quercetin | 449 (34.3%) |
| QUrol | 115 (8.8%) |
| Gabapentinoids | 79 (6.0%) |
| Acupuncture/acupressure | 10 (0.8%) |
| Physiotherapy | 33 (2.5%) |
| Antibiotics | 293 (22.4%) |
| Prostate massage | 43 (3.3%) |
*
Treatment provided by referring physician prior to or at time of evaluation of presentation to chronic prostatitis clinic.
CPSI: Chronic Prostatitis Symptom Index; QoL: quality of life; UPOINT: urinary (U), psychosocial (P), organ-specific (O), infection (I), neurogenic (N), and tenderness (T).